Medical Oncologist
CION Cancer Clinics
Surveillance for CEBPA, DDX41, ETV6 and ANKRD26 carriers | CION Cancer Clinics
Surveillance for a CEBPA, DDX41, ETV6 or ANKRD26 carrier means regular blood counts, often a baseline bone marrow test, and a clear plan for warning signs and bleeding. When checks start depends on the gene: early in life for CEBPA and ETV6, later for DDX41. This page explains which tests are used, how the plan changes through life, and which symptoms should never wait. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does surveillance involve for these carriers?
- Which tests are used to watch a carrier?
- How does the plan change through life?
- How do the plans differ between the four genes?
- What this page cannot tell you
- Four things carriers tell us, and what is actually true
- Common questions about surveillance for these genes
The short answer
What does surveillance involve for these carriers?
Regular blood counts, reviewed by a haematologist who knows your history, and in many cases one baseline bone marrow test. The aim is to notice changes in the marrow early, before a leukaemia is advanced. For carriers with low platelets, it also means keeping everyday bleeding safe.
Why the starting point differs by gene
CEBPA leukaemia can begin in childhood or young adult life, so checks and symptom awareness usually start early. ETV6 and ANKRD26 cause a low platelet count from birth, which is followed from the time the fault is found. DDX41 cancers mostly appear late in life, so regular counts usually begin in adult life, often guided by the age at which relatives were diagnosed.
Why there is no single fixed timetable
These conditions are rare and were recognised only recently. Recommendations come from expert groups rather than large trials, and centres differ in the detail. Studies so far are small, so expect your plan to be adjusted as your own results build up over the years.
Surveillance aims to find changes early. It cannot stop a gene fault from acting.The tests
Which tests are used to watch a carrier?
Four kinds of check make up most plans. Not every carrier needs all four at every visit.
Full blood count and film
The core test. It counts platelets, red cells and white cells, and a doctor looks at the cells under a microscope. Your own usual numbers matter more than the laboratory's normal range.
Baseline bone marrow test
A small sample is taken from the back of the hip bone under local anaesthetic. It records how the marrow looks at the start, so any later change can be compared with it.
Repeated when
- The blood count moves away from your usual
- New abnormal cells appear on the film
Tissue typing and donor planning
A blood test of immune markers, called HLA, used to find a matching stem cell donor. Some teams do this early, while you are well. Related donors are tested for the family fault before they are chosen.
A bleeding assessment
Mainly for ETV6 and ANKRD26 carriers. Questions about bruising, nosebleeds, periods and past surgery decide what cover you need before dental work, an operation or childbirth.
Not sure whether this applies to you?
Ask an oncologistOver time
How does the plan change through life?
-
When the fault is first found
A full blood count, a blood film and a detailed family history. Many carriers also have a baseline marrow test. You are given a named haematologist and a written plan.
-
Childhood, for CEBPA and ETV6
A paediatric haematologist follows the child. Parents learn the warning signs, because CEBPA leukaemia often arrives without any earlier change in the count.
-
Adult life, for all four genes
Counts continue on the schedule your haematologist sets, often about once a year when all is stable. DDX41 carriers usually start here, or earlier if a relative was diagnosed young.
-
When something changes
A falling count or new abnormal cells leads to a repeat marrow test. This is the moment surveillance exists for, and acting early widens the choices.
-
Before any procedure
For carriers with low platelets, dental extractions, surgery and childbirth are planned ahead. The team may give a medicine to help clotting, or a platelet transfusion.
!
What should never wait for the next appointment
A fever with shivering, bleeding that will not stop with firm pressure, black stools, vomiting blood, or a sudden crop of tiny red spots on the skin needs a doctor the same day. Go to the nearest emergency department and say you carry an inherited blood cancer gene fault. Do not take aspirin or ibuprofen for pain, because both make platelets work less well.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
At a glance
How do the plans differ between the four genes?
Gene
Usual focus of surveillance
CEBPA
Counts and symptom awareness from childhood, with early donor planning
DDX41
Regular counts in adult life, earlier if relatives were diagnosed young
ETV6
Counts from diagnosis, a bleeding plan, and awareness of childhood leukaemia signs
ANKRD26
Counts from diagnosis and a bleeding plan, watching for a change from your usual low
All four
Related donors tested for the family fault before being chosen
Being straight with you
What this page cannot tell you
It cannot set your personal schedule. How often you are seen depends on your gene, your age, your counts and your family history. What your specific variant means is a question for the counsellor who ordered the test. What a change in your blood count means is a question for your haematologist.
Keeping going from a district
Surveillance only works if it continues for years. A routine count from a reliable local laboratory can often be sent to your haematologist, so only key visits need travel to Hyderabad. Try to use the same laboratory each time, and keep every report in date order in one folder.
Who this does not apply to
This plan is for people with a confirmed inherited fault. It does not apply to someone whose change was found only inside leukaemia cells, or to a relative who has tested negative for the family variant. Most people with a low platelet count do not need this kind of follow-up.
Commonly believed
Four things carriers tell us, and what is actually true
"My count has always been low, so a low result means nothing."
Your usual low is your baseline. What matters is a change from it, which is why every report should be compared with the last few.
"I feel fine, so I can skip this year's blood test."
Early marrow change usually causes no symptoms at all. The blood test is the only way to see it before it becomes urgent.
"A clear marrow test means I am safe for good."
A marrow test describes that moment only. The value comes from repeating the blood counts, so that a change is caught between one normal result and the next.
"A painkiller from the chemist is harmless."
For carriers with low platelets, aspirin and ibuprofen-type painkillers weaken platelets further. Paracetamol is usually the safer choice, but check with your doctor first.
Questions we are asked
Common questions about surveillance for these genes
At what age should surveillance start?
It depends on the gene. For CEBPA and ETV6, usually from the time the fault is found, including in children. For ANKRD26, counts are followed from diagnosis. For DDX41, regular checks usually begin in adult life. Your haematologist will set a starting point for each person.
How often will I need a blood test?
Your haematologist decides. For a well adult carrier with stable counts, it is often about once a year. Tests become more frequent if the count starts to drift or new abnormal cells appear.
Will blood counts catch CEBPA leukaemia early?
Not always. CEBPA leukaemia often appears without any earlier change in the count. That is why knowing the warning signs matters as much as the test, and why a quick blood count is arranged whenever symptoms appear.
Which symptoms should make me call early?
New or worse bruising, bleeding gums, tiny red spots on the skin, unusual tiredness, breathlessness, repeated fevers or infections, and bone pain. None of these means leukaemia on its own, but each is a reason to get a blood count sooner.
Can surveillance prevent leukaemia?
No. It aims to find marrow changes early, when there are more treatment choices, including a planned stem cell transplant. Whether early action improves long-term results is still being studied.
Why does donor planning start while I am well?
If a transplant is ever needed, there may be little time. A brother or sister who carries the same fault should not be the donor, so testing and tissue typing early avoids a rushed search later.
What should I tell my dentist or surgeon?
If you carry ETV6 or ANKRD26, say you have an inherited low platelet count and may bleed more than expected. Ask them to speak with your haematologist before any extraction or operation. Keep a note on your phone naming the condition and your haematologist.
Does surveillance cost a lot?
Routine blood counts are inexpensive. Marrow tests and gene panels cost more but are needed less often. Ask the team for an estimate, and whether Aarogyasri or Ayushman Bharat covers any part in your situation.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Hematologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. One helpline books a consultation at any of these centres, and your team will tell you where counselling and testing take place.
Warangal
Vizag
Sources
- GeneReviews (NCBI) — CEBPA-Associated Familial Acute Myeloid Leukemia (AML)
- MedlinePlus Genetics — ETV6 gene
- MedlinePlus Genetics — ANKRD26 gene
- Cancer Research UK — Acute myeloid leukaemia (AML)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
CEBPA, DDX41, ETV6 and ANKRD26: which cancers and what riskWhat surveillance is watching for, and whyCEBPA, DDX41, ETV6 and ANKRD26 positive: what happens nextThe first steps after a positive resultTesting the family for these genesWho is tested next, including possible donorsWhy adult-onset leukaemia can still be inheritedWhy DDX41 checks start later in life
Talk to us
Need a surveillance plan after one of these results?
Share your result and any blood count reports you have. We will arrange a haematologist to set a plan that fits your gene, your age and where you live. One helpline serves every CION centre.